Matrix
Matrix is a San Francisco based venture capital firm founded in 1977 that backs early-stage companies across AI, B2B, consumer, fintech, health tech, and infrastructure. It works with product teams from idea through Series A, offering hands-on support and strategic guidance to help portfolio companies reach scale. The team comprises former founders and operators who bring practical insight to building startups. Matrix operates globally, including Matrix Partners China, which builds long-term relationships with entrepreneurs in China and abroad and invests across sectors and stages. Over its history, Matrix has backed companies that progressed to IPOs or acquisitions, reflecting a focus on durable growth and long-term value creation through close founder collaboration and a global network.
Top Sectors
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in EEG
NeuraMatrix
Series A in 2021
NeuraMatrix is an innovative developer of brain-computer interface technology, specializing in advanced neural interfaces that facilitate communication between humans and computers. The company's comprehensive approach includes both hardware and software solutions, aiming to enhance human interaction with technology and advance research in brain science and neurological diseases. NeuraMatrix focuses on improving diagnosis, treatment, and drug development for neurological conditions while leveraging the significant commercial potential of its brain-computer interface technologies. Recently, the company secured significant funding to support research and development efforts, including the update of R&D equipment, mass production of chips, product iterations, and market promotion. Through its pioneering efforts, NeuraMatrix is positioned to influence the future of neuroscience research and its practical applications.
NeuraMatrix
Seed Round in 2021
NeuraMatrix is an innovative developer of brain-computer interface technology, specializing in advanced neural interfaces that facilitate communication between humans and computers. The company's comprehensive approach includes both hardware and software solutions, aiming to enhance human interaction with technology and advance research in brain science and neurological diseases. NeuraMatrix focuses on improving diagnosis, treatment, and drug development for neurological conditions while leveraging the significant commercial potential of its brain-computer interface technologies. Recently, the company secured significant funding to support research and development efforts, including the update of R&D equipment, mass production of chips, product iterations, and market promotion. Through its pioneering efforts, NeuraMatrix is positioned to influence the future of neuroscience research and its practical applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.